Hongweiye Biological Technology Co., Lim

Country/Region: China     State/Province: Hong Kong

Main Products: Etizolam, 2fdck, Dibutylone, Bk-epdp, 4f-pvp, U-48800

Company Introduction
etizolam,2fdck,dibutylone,bk-epdp,4f-pvp,u-48800
Company Overview

Business Type: Exporter, Services

Year Established: 2003

Employees: Above 1000 People

Plant Area: 5,000-10,000 square meters

Business Information

Main Markets: South America 9% Africa 8% Eastern Asia 8% Domestic Market 9% North America 9% Eastern Europe 11% Southern Europe 11% Mid East 9% Northern Europe 10% Oceania 16%

Trade Capacity: FOB, FAS, Express Delivery

Contract Manufacturing: OEM Service Offered

Nearest Port: Hong Kong

Trade & Financial Information

Annual Revenue: US$5 Million - US$10 Million

Total Revenue: US$10 Million - US$50 Million

Export Revenue: US$10 Million - US$50 Million

Annual Output: US$10 Million - US$50 Million

Registered Capital: US$50 Million - US$100 Million

Export Percentage: 11% - 20%

Payment Modes: USD, EUR, CHF

Lead Time: 34 days

Import/Export Mode: Have Own Export License

Product Showcase
etizolam
2fdck
dibutylone
bk-epdp
4f-pvp
u-48800

CL-Link > Health & Medicines in China Health & Medicines in Hong Kong Health Care Supplement in China Health Care Supplement in Hong Kong